Your browser doesn't support javascript.
loading
Effects of pneumococcal conjugate vaccines on reducing the risk of respiratory disease associated with coronavirus infection.
Dunne, Eileen M; Nunes, Marta C; Slack, Mary P E; Theilacker, Christian; Gessner, Bradford D.
Affiliation
  • Dunne EM; Pfizer Vaccines, Collegeville, PA, USA. eileen.dunne@pfizer.com.
  • Nunes MC; Center of Excellence in Respiratory Pathogens, Hospices Civils de Lyon and Centre International de Recherche en Infectiologie (CIRI) Inserm U1111, CNRS UMR5308, ENS de Lyon, Université Claude Bernard, Lyon 1, Lyon, France.
  • Slack MPE; South African Medical Research Council, Vaccines & Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Theilacker C; School of Medicine & Dentistry, Griffith University, Gold Coast Campus, Southport, QLD, Australia.
  • Gessner BD; Pfizer Vaccines, Collegeville, PA, USA.
Pneumonia (Nathan) ; 15(1): 10, 2023 May 25.
Article in En | MEDLINE | ID: mdl-37226198
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Language: En Journal: Pneumonia (Nathan) Year: 2023 Document type: Article Affiliation country: United States Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Language: En Journal: Pneumonia (Nathan) Year: 2023 Document type: Article Affiliation country: United States Country of publication: United kingdom